Hypertension Diagnostics Inc (HDII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 06-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -125 | -369 | -622 | -1,263 | N/A |
| Depreciation Amortization | 36 | 31 | 35 | 137 | 30 |
| Accounts receivable | -17 | -16 | -16 | -149 | N/A |
| Accounts payable and accrued liabilities | 24 | 22 | 21 | 171 | N/A |
| Other Working Capital | -302 | 250 | 200 | 61 | -300 |
| Other Operating Activity | -5 | -4 | -3 | 53 | 80 |
| Operating Cash Flow | $-389 | $-86 | $-385 | $-990 | $-190 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | -2 | -631 | -490 |
| Other Investing Activity | 0 | 0 | 0 | 125 | 0 |
| Investing Cash Flow | $-2 | $-2 | $-2 | $-506 | $-490 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 189 | 183 | 264 | 955 | N/A |
| Debt Repayment | N/A | N/A | N/A | -19 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -8 | 430 |
| Financing Cash Flow | $189 | $183 | $264 | $927 | $430 |
| Beginning Cash Position | 285 | 190 | 313 | 754 | N/A |
| End Cash Position | 83 | 285 | 190 | 75 | N/A |
| Net Cash Flow | $-202 | $95 | $-123 | $-679 | $-250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -389 | -86 | -385 | -990 | -190 |
| Capital Expenditure | -2 | -2 | -2 | -631 | N/A |
| Free Cash Flow | -391 | -88 | -387 | -1,621 | -190 |